$DHR stock has now fallen 3% today, according to our price data from Polygon. There has been approximately $221,735,073 of trading volume.
It has been the 192nd most-searched ticker on Quiver Quantitative over the last day, out of 10,455 total tickers searched.
Here is what we see in our data on $DHR (you can track the company live on Quiver's $DHR stock page):
$DHR Insider Trading Activity
$DHR insiders have traded $DHR stock on the open market 13 times in the past 6 months. Of those trades, 0 have been purchases and 13 have been sales.
Here’s a breakdown of recent trading of $DHR stock by insiders over the last 6 months:
- MITCHELL P RALES (Chairman of Exec. Committee) has made 0 purchases and 6 sales selling 477,625 shares for an estimated $104,925,233.
- BRIAN W ELLIS (Senior Vice President - GC) has made 0 purchases and 2 sales selling 21,776 shares for an estimated $4,773,863.
- MATTHEW MCGREW (EVP & Chief Financial Officer) sold 16,172 shares for an estimated $3,470,831
- TERI LIST has made 0 purchases and 2 sales selling 6,076 shares for an estimated $1,333,316.
- GEORGEANN COUCHARA (SVP, Human Resources) has made 0 purchases and 2 sales selling 5,174 shares for an estimated $1,088,703.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$DHR Hedge Fund Activity
We have seen 860 institutional investors add shares of $DHR stock to their portfolio, and 1,221 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO added 11,254,213 shares (+152.3%) to their portfolio in Q3 2025, for an estimated $2,231,260,269
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 3,705,143 shares (+58.2%) to their portfolio in Q3 2025, for an estimated $734,581,651
- WELLINGTON MANAGEMENT GROUP LLP removed 3,517,388 shares (-20.6%) from their portfolio in Q3 2025, for an estimated $697,357,344
- CAPITAL WORLD INVESTORS removed 3,362,885 shares (-87.3%) from their portfolio in Q3 2025, for an estimated $666,725,580
- EAGLE CAPITAL MANAGEMENT LLC added 3,322,689 shares (+116.2%) to their portfolio in Q3 2025, for an estimated $658,756,321
- HOLOCENE ADVISORS, LP removed 2,450,999 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $485,935,061
- BANK OF NEW YORK MELLON CORP removed 2,362,560 shares (-28.1%) from their portfolio in Q3 2025, for an estimated $468,401,145
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$DHR Government Contracts
We have seen $125,898,602 of award payments to $DHR over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- MOLECULAR DIAGNOSTIC TESTS FOR SARS-COV-2: $3,970,565
- POLYMERASE CHAIN REACTION (PCR) DIAGNOSTIC TESTING FOR VISN 2 DOWNSTATE: $3,781,390
- AB SCIEX SERVICE & MAINTENANCE AGREEMENT SUPPORT: $3,403,150
- IN-VITRO REAGENTS - VISN 15, ORDERING PERIOD ONE: $2,952,609
- MICROBIOLOGY REAGENTS & CONSUMABLES ADD CLAUSE 852.222-71 - COMPLIANCE WITH EXECUTIVE ORDER 13899: $2,353,640
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
$DHR Congressional Stock Trading
Members of Congress have traded $DHR stock 6 times in the past 6 months. Of those trades, 3 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $DHR stock by members of Congress over the last 6 months:
- REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 1 purchase worth up to $15,000 on 10/07 and 1 sale worth up to $15,000 on 11/13.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 07/22 and 1 sale worth up to $15,000 on 09/25.
- REPRESENTATIVE THOMAS H. KEAN, JR. purchased up to $15,000 on 09/03.
- SENATOR SHELDON WHITEHOUSE sold up to $15,000 on 08/28.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$DHR Analyst Ratings
Wall Street analysts have issued reports on $DHR in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Goldman Sachs issued a "Buy" rating on 12/09/2025
- Barclays issued a "Overweight" rating on 10/22/2025
- TD Cowen issued a "Buy" rating on 10/22/2025
- Evercore ISI Group issued a "Outperform" rating on 10/07/2025
- B of A Securities issued a "Buy" rating on 09/22/2025
- Guggenheim issued a "Buy" rating on 07/23/2025
- Baird issued a "Outperform" rating on 07/23/2025
To track analyst ratings and price targets for $DHR, check out Quiver Quantitative's $DHR forecast page.
$DHR Price Targets
Multiple analysts have issued price targets for $DHR recently. We have seen 12 analysts offer price targets for $DHR in the last 6 months, with a median target of $247.5.
Here are some recent targets:
- Brandon Couillard from Wells Fargo set a target price of $240.0 on 12/15/2025
- Evie Koslosky from Goldman Sachs set a target price of $265.0 on 12/09/2025
- Kallum Titchmarsh from Morgan Stanley set a target price of $270.0 on 12/02/2025
- Luke Sergott from Barclays set a target price of $250.0 on 10/22/2025
- Dan Brennan from TD Cowen set a target price of $260.0 on 10/22/2025
- Ed Ridley-Day from Rothschild & Co set a target price of $220.0 on 10/08/2025
- Vijay Kumar from Evercore ISI Group set a target price of $245.0 on 10/07/2025
You can track data on $DHR on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
